Skip to main content
Doctor Unite A SKIPTA COMMUNITY
  • Home
  • Discussions
  • News
  • Resources
    • Showcases
      • All Showcases
      • An adalimumab biosimilar preferred over Humira® for your Express Scripts National Preferred Formulary & Cigna commercial formulary patients…read on
      • Attack Heart Disease

      • Better glucose health made easier with Dexcom G7
      • Breast Cancer Communication Series
      • Learn about an indication for VYVGART Hytrulo® (efgartigimod alfa and hyaluronidase-qvfc)
      • Learn more about this treatment option.
      • Migraine Communication Series
      • On-demand Lectures
      • Prescribe a COPD treatment that puts patients first
      • Skipta Soundbites
      • The COPD Treatment You Can Count On
      • VYVGART® (efgartigimod alfa-fcab) for Intravenous Infusion and VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for Subcutaneous Injection: Dosing, Mechanism of Action, Clinical Data, and More
    • Careers
    • Competes
    • Honoraria Opportunities
  • Focus Areas
    • All Focus Areas
    • ADHD
    • Alagille Syndrome Connect
    • Cardiovascular Disease Connect
    • CIDP Connect
    • CKD Connect
    • COPD Connect
    • Fabry Disease
    • Focus on Infectious Disease
    • Focus on MCED
    • gMG Connect
    • GvHD Connect
    • Heart Failure Connect
    • HIV Connect
    • Lipid Management Connect
    • Obesity Connect
    • Postpartum Depression (PPD)
    • Rheumatoid Arthritis
    • Sleep Disorder Connect
    • Spinal Muscular Atrophy (SMA)
    • Type 2 Diabetes Connect
    • Immune Thrombocytopenia

© 2009-2025 Doctor Unite

  • Terms of Service
  • Privacy Policy
  • [email protected]
Powered by Skipta